Close

Noble Financial Remains Bullish on PharmAthene (PIP) Following Court Memo Opinon on Tecovirimat

August 11, 2014 11:56 AM EDT Send to a Friend
Noble Financial affirms PharmAthene (AMEX: PIP) at Buy with a target price of $8.50 following news that the company received ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login